Browse EX-10 agreements

ex102toform61526bowen2nd

VESTIS SERVICES, LLC AGREEMENT RELATING TO EMPLOYMENT AND POST-EMPLOYMENT COMPETITION SECOND AMENDED AND RESTATED EFFECTIVE JUNE 12, 2026 This Agreement is between Adam K. Bowen, the undersigned individual (“Employee”), and Vestis Services, LLC (“Vestis”), supersedes and replaces in its entirety the Vestis Services, LLC Agreement Related to Employment and Post-Employment Competition between Employee and Vestis dated February 8, 2025. RECITALS WHEREAS, Vestis is a leading provider of uniform and workplace supplies to business and industry, private and public institutions, and the general public; WHEREAS, Vestis has a proprietary interest in its business and financial plans and systems, methods of operation and other secret and confidential information, knowledge and data (“Proprietary Information”) which includes, but is not limited to, all confidential, proprietary or non-public information, ideas and concepts; annual and strategic business plans; financial plans, reports and systems including, profit and loss statements, sales, accounting forms and procedu

…

Execution Copy

June 15, 2026

Jillian C. Evanko

Senior Advisor

 

 

Re:

Amendment to Senior Advisor Agreement

Dear Jill:

Reference is hereby made to that certain Senior Advisor Agreement, dated as of November 16, 2025 (the “SAA”), by and between you and Chart Industries, Inc., a Delaware corporation (the “Company”). This letter agreement (this “Amendment”) supplements and amends the SAA, including with respect to certain provisions contained herein involving Baker Hughes Company, a Delaware corporation (“Baker Hughes”). Capitalized terms used but not defined herein shall have their respective meanings set forth in the SAA.

1. Senior Advisor Term and Fee.

a. Notwithstanding anything in the SAA to the contrary, the Senior Advisor Term shall terminate and conclude, and you shall cease providing Senior Advisor Services and cease to be eligible to accrue any further Senior Advisor Fee, effective as of the date hereof (the “Service End Date”). No Senior Advisor Fee shall accrue in respect of any period after the Service End Date.

…

---

Exhibit 10.1

Execution Version

SECURITIES PURCHASE AGREEMENT

 

THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of April 30, 2026, is between PDS BIOTECHNOLOGY CORPORATION, a company incorporated under the laws of the State of Delaware (the “Company”), and YA II PN, LTD., a Cayman Islands exempt limited company (the “Investor”).

 

WITNESSETH

 

WHEREAS, the parties desire that, upon the terms and subject to the conditions contained herein, the Company shall issue and sell to the Investor, as provided herein, and the Investor shall purchase (i) a promissory note in the form attached hereto as “Exhibit A” (the “Promissory Note”) in the aggregate principal amount of $6,000,000 (the “Principal Amount”), and (ii) a warrant in the form attached hereto as “Exhibit B” (the “Warrant”) which shall be exercisable into such number of shares of the Company’s common stock, par value $0.00033 per share (the “Common Shares”) equal to 2,158,274 (as exercised, the “Warrant Shares”). Both the Promissory Note and the Warrant shall be issued and sold by the Company and purcha

…

VICE CHAIRMAN AGREEMENT

(Advisory / Non-Board Position)

This Vice Chairman Agreement (the “Agreement”) is made and entered into as of June 12, 2026, by and between:

AI Era Corp., a Nevada corporation (the “Company”),

and

Mark Iwanowski, an individual (the “Vice Chairman”).

1.  Position

The Company hereby appoints the Vice Chairman to serve as Vice Chairman of the Company in a non-executive, advisory capacity. This position is not a position on the Board of Directors, and the Vice

Chairman shall not be a member of the Board of Directors or an “officer” of the Company for purposes of the Securities Exchange Act of 1934, as amended, or any other applicable securities laws, rules or regulations, unless and until the Board of Directors and the Vice Chairman mutually agree in writing to appoint him to the Board or designate him as an officer at a later date. The Vice Chairman acknowledges that this role is that of an independent contractor and strategic advisor to the Chairman.

2.  Term

…

EMPLOYMENT AGREEMENT

This Employment Agreement (this “Agreement”) is entered into as of June 12, 2026 (the “Effective Date”), by and Greenway Technologies, Inc., a Texas corporation (the “Company”), and Doug Cogan (“Executive”). The Company and Executive are each referred to in this Agreement as a “Party” and collectively as the “Parties.”

 

PRELIMINARY STATEMENTS

a. The Company desires to continue to employ Executive as its Chief Executive Officer, and Executive desires to be employed by the Company as its Chief Executive Officer.

 

b. The Company and Executive desire to set forth in writing the terms and conditions of their agreement and understandings with respect to Executive’s employment by the Company.

 

C. The Company hereby continues to employ Executive, and Executive hereby accepts employment with the Company, for the period and upon the terms and conditions contained in this Agreement.

 

AGREEMENT

…

GREENWAY TECHNOLOGIES, INC.

STOCK AWARD AGREEMENT

1. Grant of Award. Pursuant to the terms of this Stock Award Agreement (this “Agreement”) and in exchange for services rendered to Greenway Technologies, Inc., a Texas corporation (the “Company”), the Company hereby grants to Doug Cogan (the “Grantee”) an award of 2,500,000 shares (the “Awarded Shares”) of the Company’s common stock, $0.001 par value (“Common Stock”). The “Date of Grant” of this Award is June 12, 2026.

2. Definitions. For purposes of this Agreement, the following terms shall have the meanings set forth below:

 

(a) “Employment Agreement” means that certain Employment Agreement, dated June 12, 2026, by and between the Company and the Grantee.

…

Exhibit 10.1

 

SECURITIES PURCHASE AGREEMENT

This Securities Purchase Agreement (this “Agreement”) is dated as of June 11, 2026 between Arcadia Biosciences, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).

WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an exemption from registration requirements of Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), and Rule 506 promulgated thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement.

NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:

ARTICLE I.

DEFINITIONS

…

Exhibit 10.2

 

REGISTRATION RIGHTS AGREEMENT

 

This Registration Rights Agreement (this “Agreement”) is made and entered into as of June 11, 2026, between Arcadia Biosciences, Inc., a Delaware corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).

 

This Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereof, between the Company and each Purchaser (the “Purchase Agreement”).

 

The Company and each Purchaser hereby agrees as follows:

 

1. Definitions.

 

Capitalized terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase Agreement. As used in this Agreement, the following terms shall have the following meanings:

 

“Advice” shall have the meaning set forth in Section 6(c).

…

Execution Copy

AMENDMENT NO. 7 TO AMENDED AND RESTATED CREDIT****AGREEMENT

This AMENDMENT NO. 7 TO AMENDED AND RESTATED CREDIT AGREEMENT (this “Agreement”) is made as of June 9, 2026, by and among SAFETY INSURANCE GROUP, INC., a Delaware corporation (the “Borrower”), the lenders who are or may become party to the Credit Agreement referred to below (collectively, the “Lenders”), and CITIZENS BANK, N.A., as administrative agent for the Lenders (the “Administrative Agent”).  Capitalized terms used and not defined in this Agreement shall have the meanings ascribed thereto in the Credit Agreement referred to below.

WHEREAS, the Borrower, the Lenders, and the Administrative Agent are parties to that certain Amended and Restated Revolving Credit Agreement, dated as of August 14, 2008, among the Borrower, the Administrative Agent and the Lenders (as amended, restated or otherwise modified from time to time, the “Credit Agreement”);

…

Document

EXHIBIT 10.1

TRANSITION AND RELEASE AGREEMENT

THIS TRANSITION AND RELEASE AGREEMENT (“Agreement”) is made by and between Christopher J. Reedy (“Employee”) and Butler National Corporation, a Kansas corporation (the “Company”).

WHEREAS, Employee has provided notice to the Board of Directors of the Company (the “Board”) of his decision to retire as the Chief Executive Officer of the Company on June 15, 2026 (the “Resignation Date”);

WHEREAS, Employee has informed the Company of his intent to take a leave of absence from the Company commencing on or prior to the Resignation Date;

WHEREAS, for periods on and after the Resignation Date and continuing until the end of the day on July 1, 2027 (the “Retirement Date”), the Board desires that Employee remain employed by the Company as a Special Advisor to the Board;

WHEREAS, the Company and Employee desire to enter into this Agreement with respect to their respective rights and obligations in connection with Employee’s retirement and employment as a Special Advisor to the Board; and

…

EMPLOYMENT AGREEMENT

This Employment Agreement (the “Agreement”) is effective as of the 15th day of June, 2026 (the “Effective Date”) by and between SAFESPACE GLOBAL CORPORATION, a Nevada corporation (“SSGC”), and Michael L. Hrynuik (“Executive”).

 

NOW, THEREFORE, in consideration of the foregoing and the mutual covenants and conditions contained herein, the parties hereto agree as follows:

 

1. Employment. SSGC hereby employs Michael L. Hrynuik, to serve SSGC as an Executive Officer and, specifically as its Chief Financial Officer (“CFO”), with such specific duties and responsibilities as may be required of such a CFO and as otherwise determined by the Chairman and Chief Executive Officer (“CEO”) and/or Board of Directors of SSGC (“BOD”) from time to time. Mr. Hrynuik (“Executive”) hereby accepts such Employment upon the terms and subject to conditions set forth in this Agreement. In performing his services to SSGC, the Executive will directly report and be subject to the direction of the CEO, The Employment of the Executive

…

Execution Version

 

AMENDMENT NO. 1 TO CREDIT AGREEMENT

 

This AMENDMENT NO. 1 TO CREDIT AGREEMENT, dated as of June 15, 2026 (this “Amendment”), is entered into among AUTODESK, INC., a Delaware corporation (the “Company”), each of the Lenders signatory hereto as an “Existing Lender” (collectively, the “Existing Lenders”), and CITIBANK, N.A., as administrative agent for the Lenders (in such capacity, the “Administrative Agent”) under the Credit Agreement, dated as of May 8, 2025 (as amended, supplemented or otherwise modified from time to time prior to the date hereof, the “Credit Agreement”), among the Company, the Lenders thereto and the Administrative Agent.

 

WHEREAS, the Company and the Existing Lenders party hereto (which constitute the Required Lenders) desire to amend the Credit Agreement on the Amendment Effective Date (as defined below) pursuant to Section 8.01 of the Credit Agreement.

…